Archiv | Archiv 2018 | ESMO 2018

Welcome to Munich

ESMO 2018

Dr. med. Friedrich Overkamp

Welcome to munich

Kolorektales Karzinom

ESMO 2018

Prof. Dr. med. Anke Reinacher-Schick

Adjuvante Therapie: Liquid Biopsy

ESMO 2018

PD Dr. med. Dominik Modest

CRC

ESMO 2018

Prof. Dr. med. Dirk Arnold

Kolonkarzinom

ESMO 2018

Prof. Dr. med. Dirk Arnold

metastasiertes Analkarzinom

ESMO 2018

Prof. Dr. med. Anke Reinacher-Schick

VOLFI trial & NORDIC9

ESMO 2018

Prof. Dr. med. Anke Reinacher-Schick

Adjuvante Therapie: Liquid Biopsy & MOSAIC trial

Mammakarzinom

ESMO 2018

Prof. Dr. med. Peter Fasching

PD-L1-doch wieder ein Marker?

ESMO 2018

Prof. Dr. med. Diana Lüftner

IMpassion130

ESMO 2018

Prof. Dr. med. Peter Fasching

CDK4/6 QoL und OS Update

ESMO 2018

PD Dr. med. Hans-Christian Kolberg

PALOMA 3 Update

ESMO 2018

Prof. Dr. med. Peter Fasching

IMpassion130 atezolizumab + nab-paclitaxel in mTNBC

ESMO 2018

Prof. Dr. med. Diana Lüftner

CDK 4/6 Update

ESMO 2018

PD Dr. med. Hans-Christian Kolberg

Alpelisib (ALP) + fulvestrant (FUL): SOLAR-1 trial

ESMO 2018

Prof. Dr. med. Peter Fasching

SOLO 1

ESMO 2018

PD Dr. med. Hans-Christian Kolberg

Update Quality of Life

Melanom

ESMO 2018

Prof. Dr. med. Axel Hauschild

CheckMate 511

ESMO 2018

Prof. Dr. med. Axel Hauschild

Combi-AD

ESMO 2018

Dr. med. Elisabeth Livingstone

Update Combi-AD-adjuvante Therapie

ESMO 2018

Dr. med. Elisabeth Livingstone

Update Combi-AD-Biomarker

ESMO 2018

Dr. med. Elisabeth Livingstone

Melanom - neoadjuvante Therapie: OpACIN-neo

Urogenitale Tumoren

ESMO 2018

Dr. med. Gerson Lüdecke

mUC CheckMate 032

ESMO 2018

Dr. med. Gerson Lüdecke

NMIBC KEYNOTE-057

ESMO 2018

Prof. Dr. med. Viktor Grünwald

Nierenzellkarzinom JAVELIN Renal 101

Weitere

ESMO 2018

Prof. Dr. med. Viktor Grünwald

Kopf-Hals-Tumoren

ESMO 2018

Dr. Friedrich Overkamp

ASH 2018 Teaser

ESMO 2018

Dr. med. Friedrich Overkamp

SABCS 2018 Teaser

ESMO 2018

Dr. med. Friedrich Overkamp

Nobelpreis Checkpoint Inhibitoren